United States · FDA National Drug Code directory
LOTEMAX
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 24208-299_ef44228f-e365-4d7f-b143-529257efffbe
- Product NDC
- 24208-299
- Form
- SUSPENSION/ DROPS
- Composition / generic term
- loteprednol etabonate
- Labeler
- Bausch & Lomb Incorporated
- Marketing category
- NDA
- Marketing start / end (source format)
- 19980309
- Source listing expiry
- 20261231
Source-listed ingredients
- LOTEPREDNOL ETABONATE — 5 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 CARTON (24208-299-01) / 1 mL in 1 BOTTLE · 24208-299-01
- 1 BOTTLE in 1 CARTON (24208-299-05) / 5 mL in 1 BOTTLE · 24208-299-05
- 1 BOTTLE in 1 CARTON (24208-299-10) / 10 mL in 1 BOTTLE · 24208-299-10
- 1 BOTTLE in 1 CARTON (24208-299-15) / 15 mL in 1 BOTTLE · 24208-299-15
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →